GLPG0259 News
Most Popular GLPG0259 Story
Galapagos shares surge on Phase I trial launch
Shares of Belgium's Galapagos surged on today's news that researchers had pushed its experimental therapy for rheumatoid arthritis into a Phase I human trial. GLPG0259-- targets protein kinase Read more...
Latest Headlines
- March 27, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
